Mats O. Karlsson
Uppsala University
487 Papers
3.4K Citations
Mats O. Karlsson is an academic researcher from Uppsala University. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 65, co-authored 468 publications. Previous affiliations of Mats O. Karlsson include Astra & University of Colorado Boulder.
Chat about Author
Papers
Semi-mechanistic PK/PD modeling of Paracetamol and Sulfapyridine to characterize pharmacological effects on gastric emptying and small intestinal transit.
Martin Bergstrand,Sandra A.G. Visser,Linnea Sjödin,Ahmad Al-Saffar,Mats O. Karlsson +4 more
- 01 Jan 2011
TL;DR: The paracetamol (PCM) and sulfapyridine (SP) double marker technique is based on combined gastric administration of PCM and sulfasalazine followed by plasma concentration measurements forPCM and SSP.
1
•Journal Article
A mathematical disease progression model for the effect of diet and exercise in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study (FDPS)
Siti Maisharah Sheikh Ghadzi,Mats O. Karlsson,V.D.F. de Mello,M. I. J. Uusitupa,Maria C. Kjellsson +4 more
TL;DR: A mathematical disease progression model for the effect of diet and exercise in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study (FDPS) shows clear trends in disease progression.
1
A semi-mechanistic model to link in vitro and in vivo drug release for modified release formulations
Martin Bergstrand,Erik Söderlind,Ulf Eriksson,Werner Weitschies,Mats O. Karlsson +4 more
- 01 Jan 2011
TL;DR: In vivo prediction of drug release based on in-vitro experiments is important for the development of new modified release (MR) formulations and most efforts to improve such predictions have focused on single molecule predictions.
1
Simultaneous optimal experimental design for in vitro binding parameter estimation.
TL;DR: Optimize designs for in vitro ligand binding studies provided robust parameter estimation while allowing more efficient and cost effective experimentation by reducing the measurement times and separate ligand concentrations required and in some cases, the total number of samples.
1